INNPF News and Press, Innovative Properties Inc

Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Feb. 9, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("...

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering Canada NewsWire HERZLIA, Israel and CALGARY, AB , Jan. 2, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"),...

Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Dec. 10, 2025 /CNW/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQ...

Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Nov. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a pharmaceutical ...

Innocan Pharma to Present at the 2025 ThinkEquity Conference Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Oct. 24, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechn...

Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan Canada NewsWire Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan's World Third Largest Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB , Oct. 15, 2025 /CNW/...

Toronto, Ontario--(Newsfile Corp. - Le 2 septembre/September 2025) - InnoCan Pharma Corporation has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every sixty-five (65) pre-consolidated common shares. As a result...

Innocan Pharma Announces Details of Proposed Share Consolidation Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /CNW/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is p...

Innocan Pharma Announces First Half Of 2025 Financial Results Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a pharmaceuti...

Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , July 23, 2025 /CNW/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (...